| ²é¿´: 1700 | »Ø¸´: 6 | |||
| µ±Ç°Ö»ÏÔʾÂú×ãÖ¸¶¨Ìõ¼þµÄ»ØÌû£¬µã»÷ÕâÀï²é¿´±¾»°ÌâµÄËùÓлØÌû | |||
zxb1980083ͳæ (ÕýʽдÊÖ)
|
[½»Á÷]
¹ØÓÚôDZû»ù±¶Ëû»·ºý¾«µÄ¿Ú·þÎÊÌâ ÒÑÓÐ5È˲ÎÓë
|
||
|
´ó¼ÒÓÐûÓÐ×öôDZû»ù±¶Ëû»·ºý¾«¿Ú·þÖÆ¼ÁµÄ£¿ ÎÒÏÖÔÚ×öÒ»¸ö¿¹°©Ò©Î¶¯ÎïʵÑéÊÇÓÃôDZû»ù±¶Ëû»·ºý¾«ºÍÒ©Îï»ìºÏÈ»ºó¼ÓË®½«Èܽ⣬Ȼºó¿Ú·þ¹àθ¡£ÎÒÏëÎÊÏÂÁÙ´²ÉÏÒ²¿ÉÒÔÕâÑù×ö³É¿Ú·þ³å¼ÁÂ𣿠ÁíÍâôDZû»ù±¶Ëû»·ºý¾«×÷ΪҩÓø¨ÁÏÎÒ×ÉѯÁËһϣ¬ÓеÄÈË˵¿ÉÒÔÓÃ×÷¿Ú·þµÄ£¬ÓеÄÈË˵²»¿ÉÒÔÓÃÓÉÓÚËüµÄ°²È«ÐÔ¡£ ÏÖÔÚ¾ÍÊǵ·²»Çå³þ£¬¾¿¾¹¿É²»¿ÉÒÔÓÃ×÷¿Ú·þ¸¨ÁÏ¡£°´ÕÕ¶¯×÷ʵÑéµÄ½á¹û£¬ÎÒÃÇÈç¹ûÓõ½ÁÙ´²µÄ»°£¬Ã¿Ìì¿Ú·þÁ½´Î£¬Ã¿´ÎÓÃÁ¿´ïµ½3.6g¡£Ï൱ÓÚÿÌìÒª³Ô7.2gµÄÁ¿¡£Ò»¸öÔÂÒ»¸öÁƳÌÕâÑù¶ÔÈËÉí°²È«ÐÔ¿ÉÒÔͨ¹ý¹ú¼ÒµÄÐÂÒ©ÆÀÉóÂ𣿠´ó¼Ò¹ýÀ´ÌÖÂÛһϣ¬»¥Ïàѧϰ³É³¤¡£ |
» ²ÂÄãϲ»¶
2026Äê8ÔÂ25ÈÕ¹ú×ÔÈ»·Å°ñǰͻȻÊÕµ½ÁÐÈëÆÀÉóר¼ÒÓʼþ£¬ÓйØÏµÂð£¿
ÒѾÓÐ18È˻ظ´
ÊÛSCIÒ»ÇøT0PÎÄÕ£¬ÎÒ:8.O.55.1.O.5.4,¿ÆÄ¿È«,¿É+¼±
ÒѾÓÐ3È˻ظ´
½ñÌìÎñί»á¿ªÍêÁË£¬Ã÷Ìì³ö½á¹ûÂð
ÒѾÓÐ21È˻ظ´
ÔÚ¼á±ù»¹¸Ç×ű±º£µÄʱºò£¬ÎÒ¿´µ½ÁËŷŵÄ÷»¨¡£
ÒѾÓÐ9È˻ظ´
Ã÷ÌìÓ¦¸Ã¿É²éÁË£¡£¿
ÒѾÓÐ6È˻ظ´
ÓÐûÓдóÉñ°ïÎÒ¿´¿´»ù½ð´úÂë
ÒѾÓÐ10È˻ظ´
·Å°ñǰµÄ²»µ¶¨
ÒѾÓÐ19È˻ظ´
ijЩ»ú¹¹£¬ÒÔЧÂʵÍΪÈÙ£¬ÒÔЧÂʵÍ×÷Ϊ´æÔÚ¸Ð
ÒѾÓÐ10È˻ظ´
2026¹ú×ÔÈ»º¯ÆÀ·Ñµ½ÕË
ÒѾÓÐ23È˻ظ´
½ñÈÕ²»·Å°ñ£¿Íø´«¹ú×ÔȻԤ¼Æ 8 Ô 27 Èտɲé½á¹û
ÒѾÓÐ22È˻ظ´
» ±¾Ö÷ÌâÏà¹Ø¼ÛÖµÌùÍÆ¼ö£¬¶ÔÄúͬÑùÓаïÖú:
ÇóÖú¹ØÓڦ»·ºý¾«ÔÚ¿Ú·þ¸øÒ©ÖеÄ×î´óÓÃÁ¿
ÒѾÓÐ9È˻ظ´
ÈçºÎ²â¶¨ôDZû»ù-¦Â-»·ºý¾«°üºÏÎïÖеÄÒ©ÎﺬÁ¿
ÒѾÓÐ12È˻ظ´
°ïæ·ÖÎöһϣ¬¹ØÓÚ»·ºý¾«°üºÏÎïµÄNMRÎÊÌâ
ÒѾÓÐ5È˻ظ´
¡¾ÇóÖú¡¿»·ºý¾«°üºÏÖÐÓöµ½µÄÎÊÌ⣺Ũ¶ÈºÍ°üºÏ×÷Óò»³ÉÏßÐÔ
ÒѾÓÐ21È˻ظ´
¡¾ÇóÖú¡¿¹ØÓÚ»·ºý¾«ÈÛµãµÄÎÊÌâ
ÒѾÓÐ6È˻ظ´
¡¾½»Á÷¡¿ôDZû»ù±¶Ëû»·ºý¾«°üºÏÎïµÄ¿¼²ìÒòËØ
ÒѾÓÐ10È˻ظ´
¡¾ÇóÖú¡¿¦Â-»·ºý¾«°üºÏµÄһЩÎÊÌâ
ÒѾÓÐ11È˻ظ´
Matt Luo
гæ (ÕýʽдÊÖ)
- Ó¦Öú: 3 (Ó×¶ùÔ°)
- ½ð±Ò: 791.9
- ºì»¨: 15
- Ìû×Ó: 652
- ÔÚÏß: 72.6Сʱ
- ³æºÅ: 3991348
- ×¢²á: 2015-07-26
- רҵ: ÉúÎï¼¼ÊõÒ©Îï
5Â¥2017-08-30 06:50:20
ypsucker
гæ (³õÈëÎÄ̳)
- Ó¦Öú: 0 (Ó×¶ùÔ°)
- ½ð±Ò: 2
- Ìû×Ó: 2
- ÔÚÏß: 42·ÖÖÓ
- ³æºÅ: 1762849
- ×¢²á: 2012-04-18
¡ï
Сľ³æ: ½ð±Ò+0.5, ¸ø¸öºì°ü£¬Ð»Ð»»ØÌû
Сľ³æ: ½ð±Ò+0.5, ¸ø¸öºì°ü£¬Ð»Ð»»ØÌû
|
ôDZû»ù±¶Ëû»·ºý¾«±ð˵¿Ú·þ£¬×¢Éä¶¼ÊÇ¿ÉÒԵģ¬ÏÂÃæ×ÊÁϹ©Äã²Î¿¼ INACTIVE INGREDIENT6 ROUTE;DOSAGE FORM7 CAS NUMBER8 UNII9 MAXIMUM POTENCY10 ________________________________________ GAMMA CYCLODEXTRIN INTRAVENOUS; INJECTION KZJ0BYZ5VA 5% ________________________________________ HYDROXYPROPYL-BCYCLODEXTRIN INTRAVENOUS; POWDER, FOR INJECTION SOLUTION, LYOPHILIZED 128446355 1I96OHX6EK ________________________________________ HYDROXYPROPYL-BCYCLODEXTRIN IV(INFUSION); INJECTION 128446355 1I96OHX6EK 0.4% ________________________________________ HYDROXYPROPYL-BCYCLODEXTRIN IV(INFUSION); POWDER, FOR INJECTION SOLUTION, LYOPHILIZED 128446355 1I96OHX6EK ________________________________________ HYDROXYPROPYL-BCYCLODEXTRIN ORAL; SOLUTION 128446355 1I96OHX6EK 40% ________________________________________ SULFOBUTYLETHER .BETA.-CYCLODEXTRIN INTRAMUSCULAR; POWDER, FOR INJECTION SOLUTION, LYOPHILIZED, WITH ADDITIVES 2PP9364507 44.149% ________________________________________ SULFOBUTYLETHER .BETA.-CYCLODEXTRIN IV(INFUSION); POWDER, FOR INJECTION SOLUTION, LYOPHILIZED 2PP9364507 ________________________________________ |
2Â¥2012-04-18 13:47:28
Matt Luo
гæ (ÕýʽдÊÖ)
- Ó¦Öú: 3 (Ó×¶ùÔ°)
- ½ð±Ò: 791.9
- ºì»¨: 15
- Ìû×Ó: 652
- ÔÚÏß: 72.6Сʱ
- ³æºÅ: 3991348
- ×¢²á: 2015-07-26
- רҵ: ÉúÎï¼¼ÊõÒ©Îï
4Â¥2017-08-30 06:48:51
ÉòÌìÅô
гæ (³õÈëÎÄ̳)
- Ó¦Öú: 0 (Ó×¶ùÔ°)
- ½ð±Ò: 13.5
- Ìû×Ó: 5
- ÔÚÏß: 35·ÖÖÓ
- ³æºÅ: 7393508
- ×¢²á: 2017-10-30
6Â¥2018-05-23 14:25:11









»Ø¸´´ËÂ¥
28